HomeCDXS • NASDAQ
add
Codexis Inc
Previous close
$3.37
Day range
$3.35 - $3.43
Year range
$1.51 - $4.90
Market cap
241.86M USD
Avg Volume
788.30K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | 7.98M | -62.58% |
Operating expense | 15.67M | 17.25% |
Net income | -22.76M | -97.47% |
Net profit margin | -285.19 | -427.74% |
Earnings per share | -0.32 | -89.37% |
EBITDA | -21.30M | -92.37% |
Effective tax rate | -0.04% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 73.20M | -20.52% |
Total assets | 132.01M | -36.16% |
Total liabilities | 70.56M | -14.61% |
Total equity | 61.45M | — |
Shares outstanding | 70.93M | — |
Price to book | 3.87 | — |
Return on assets | -40.07% | — |
Return on capital | -49.82% | — |
Cash Flow
Net change in cash
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -22.76M | -97.47% |
Cash from operations | -12.17M | 24.36% |
Cash from investing | -27.09M | -1,624.19% |
Cash from financing | -197.00K | -102.85% |
Net change in cash | -39.45M | -267.51% |
Free cash flow | -4.35M | 56.61% |
About
Codexis, Inc. is a protein engineering company that develops enzymes for pharmaceutical, food and medical applications. Wikipedia
CEO
Founded
2002
Headquarters
Website
Employees
174